Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimization and in Vivo Validation of Peptide Vectors Targeting the LDL Receptor.
Jacquot G, Lécorché P, Malcor JD, Laurencin M, Smirnova M, Varini K, Malicet C, Gassiot F, Abouzid K, Faucon A, David M, Gaudin N, Masse M, Ferracci G, Dive V, Cisternino S, Khrestchatisky M. Jacquot G, et al. Among authors: masse m. Mol Pharm. 2016 Dec 5;13(12):4094-4105. doi: 10.1021/acs.molpharmaceut.6b00687. Epub 2016 Oct 11. Mol Pharm. 2016. PMID: 27656777
Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier.
Molino Y, David M, Varini K, Jabès F, Gaudin N, Fortoul A, Bakloul K, Masse M, Bernard A, Drobecq L, Lécorché P, Temsamani J, Jacquot G, Khrestchatisky M. Molino Y, et al. Among authors: masse m. FASEB J. 2017 May;31(5):1807-1827. doi: 10.1096/fj.201600827R. Epub 2017 Jan 20. FASEB J. 2017. PMID: 28108572
We thus provide further evidence that LDLR is a relevant receptor for CNS drug delivery via receptor-mediated transcytosis and that the peptide vectors we developed have the potential to transport drugs, including proteins or Ab based, across the BBB.-Molino, Y., David, M. …
We thus provide further evidence that LDLR is a relevant receptor for CNS drug delivery via receptor-mediated transcytosis and that the pept …
Identification and characterization of highly versatile peptide-vectors that bind non-competitively to the low-density lipoprotein receptor for in vivo targeting and delivery of small molecules and protein cargos.
David M, Lécorché P, Masse M, Faucon A, Abouzid K, Gaudin N, Varini K, Gassiot F, Ferracci G, Jacquot G, Vlieghe P, Khrestchatisky M. David M, et al. Among authors: masse m. PLoS One. 2018 Feb 27;13(2):e0191052. doi: 10.1371/journal.pone.0191052. eCollection 2018. PLoS One. 2018. PMID: 29485998 Free PMC article.
Canadian Highly Sensitized Patient Program Report: A 1000 Kidney Transplants Story.
Shamseddin MK, Paraskevas S, Mainra R, Maru K, Piggott B, Jagusic D, Yetzer K, Gunaratnam L, Ribic C, Kim J, Singh S, Hoar S, Prasad GVR, Masse M, Houde I, Khalili M, West K, Liwski R, Martin S, Gogan N, Karpinski M, Monroy-Cuadros M, Gourishankar S, Johnston O, Lan J, Nguen C, Gill J, Pâquet M. Shamseddin MK, et al. Among authors: masse m. Can J Kidney Health Dis. 2024 Dec 24;11:20543581241306811. doi: 10.1177/20543581241306811. eCollection 2024. Can J Kidney Health Dis. 2024. PMID: 39735689 Free PMC article.
Enrolment patterns in a randomized controlled trial of probiotics in critically ill patients: a retrospective analysis of the PROSPECT trial.
Takaoka A, Johnstone J, Lauzier F, Heels-Ansdell D, Davis M, Zytaruk N, Duan E, Dionne J, Saunders L, Arabi YM, Marshall J, Thabane L, Clarke F, Hand L, Masse MH, Rochwerg B, McIntyre L, Girard M, Freitag A, Karachi T, Cook DJ; PROSPECT Investigators; Canadian Critical Care Trials Group. Takaoka A, et al. Among authors: masse mh. Trials. 2024 Dec 27;25(1):851. doi: 10.1186/s13063-024-08701-w. Trials. 2024. PMID: 39731129 Free PMC article. Clinical Trial.
Blood Pressure Targets for Adults with Vasodilatory Shock - An Individual Patient Data Meta-Analysis.
Angriman F, Momenzade N, Adhikari NKJ, Mouncey PR, Asfar P, Yarnell CJ, Ong SWX, Pinto R, Doidge JC, Shankar-Hari M, Harhay MO, Masse MH, Harrison DA, Rowan KM, Li F, Carter F, Camirand-Lemyre F, Lamontagne F. Angriman F, et al. Among authors: masse mh. NEJM Evid. 2025 Jan;4(1):EVIDoa2400359. doi: 10.1056/EVIDoa2400359. Epub 2024 Nov 18. NEJM Evid. 2025. PMID: 39556565
219 results